Ancient Seaweed SLASHES High Blood Pressure (ZERO Side Effects)
Could a simple seaweed deliver what NO prescription drug can…
Lower blood pressure in just weeks… without ANY side effects?
If you’re struggling to control your high blood pressure, you know it’s a long ride on the Big Pharma carousel.
There’s a 59% chance you’re going to end up on multiple blood pressure drugs – and they come with life-altering side effects like constant dizziness, fatigue, and problems in the bedroom.
But years ago, researchers noticed something unusual about people living along the rocky shores of Korea and Japan.
They consistently had lower blood pressure… better circulation… and less arterial stiffening.
Now, scientists have discovered their secret—a seaweed they’ve been eating for generations, that practically forces your blood pressure to drop.
It’s safe… affordable… you can get it in capsule form… and it’s now available for all Americans.
If you know where to look…
That seaweed is Ecklonia cava—a dark brown seaweed that clings to rocky underwater surfaces in the cold currents off Korea and Japan.
What those coastal communities had been eating for generations turned out to contain something pharmaceutical companies have been trying to synthesize for DECADES…
A natural ACE inhibitor. ACE—angiotensin-converting enzyme—is the target of some of the world’s most prescribed blood pressure drugs. Lisinopril. Enalapril. Ramipril.
They all work the same way: by blocking the enzyme that produces angiotensin II, a compound that tightens blood vessels and drives pressure up.
Block ACE, and vessels relax. Blood flows easier. Pressure drops.
That’s exactly what Ecklonia cava does. But instead of being synthesized in a lab, it’s been growing in the ocean for millennia.
The active compounds are called phlorotannins—powerful polyphenols unique to marine algae. These have a molecular structure specifically suited to blocking ACE, which is why researchers finally understood the cardiovascular protection those coastal populations had been experiencing all along.
Korean scientists designed a 12-week, double-blind, placebo-controlled trial with 97 overweight adults who had elevated blood pressure but hadn’t yet started medication.
Three groups: placebo, low-dose (72mg daily), and standard-dose (144mg daily).
After 12 weeks, the 144mg group showed something remarkable…
Systolic blood pressure—the number that matters most for heart disease risk—dropped 2.6%. Blood glucose decreased significantly.
But what made researchers really take notice was that there were zero significant side effects.
There’s not a blood pressure drug on the market that can promise that.
And Ecklonia cava does more than block ACE.
It also increases nitric oxide in your blood vessel walls—helping vessels relax and widen naturally. It boosts antioxidant activity that protects artery walls from the kind of oxidative damage that accelerates heart disease.
Ecklonia cava is practically unknown in the United States, so you’ll probably never hear your doctor mention it.
But it is now available in supplement form – usually called SeaPolynol or brown seaweed extract.
The dose that worked in the study was 144mg daily. Look for products standardized to at least 30% phlorotannins.
Remember, effects showed up after 12 weeks of consistent use. Not overnight, but relatively quickly for cardiovascular changes. If you’re already taking blood pressure medication, talk to your doctor before adding this.
High blood pressure damages your arteries every single day. Every point you bring it down reduces your risk of stroke, heart attack, kidney failure, and dementia.
Coastal communities have been eating this seaweed for thousands of years. Their hearts tell the story. Maybe it’s time yours did, too.
To healthier vessels, whatever the source,
Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team
Sources:
- Shin HC, Kim SH, Park Y, Lee BH, Hwang HJ. Effects of 12-week oral supplementation of Ecklonia cava polyphenols on anthropometric and blood lipid parameters in overweight Korean individuals: a double-blind randomized clinical trial. Phytotherapy Research. 2012;26(3):363-368. https://pubmed.ncbi.nlm.nih.gov/21717516/
- Jung HA, Hyun SK, Kim HR, Choi JS. Angiotensin-converting enzyme I inhibitory activity of phlorotannins from Ecklonia stolonifera. Fisheries Science. 2006;72(6):1292-1299. Park E, Ahn GN, Lee NH, et al. Radioprotective properties of ecklonia cava polysaccharides against ionizing radiation in mice. FEBS Letters. 2008;582(8):1217-1222. https://pubmed.ncbi.nlm.nih.gov/21556221/
- Lee SH, Jeon YJ. Anti-diabetic effects of brown algae derived phlorotannins, marine polyphenols through diverse mechanisms. Fitoterapia. 2013;86:129-136. https://pubmed.ncbi.nlm.nih.gov/35717781/


